Sunway Healthcare Berhad has priced its initial public offering at RM1.45 per share, raising RM2.86 billion in Malaysia’s largest listing in nine years and a watershed moment for the country’s fast‑growing private hospital sector. The hospital arm of Sunway Berhad will list on Bursa Malaysia’s main market on March 20, with cornerstone investors including KWAP, EPF and GIC committing RM1.2 billion at the IPO price.
The IPO comprises 1.97 billion new shares, representing 25 per cent of post‑IPO share capital. Proceeds will fund Sunway Medical Centre Velocity (500 beds) in Cheras and Sunway StarOne (300 beds) in Penang, plus debt repayment and working capital. Forecast FY26 distribution yield of 3.8 per cent at IPO price implies forward P/E of 28 times.
Sunway operates five JCI‑accredited hospitals with 1,312 beds and 2.5 million annual patient visits. Revenue grew 18 per cent CAGR to RM1.8 billion in FY25. EBITDA margin expanded to 26 per cent from 22 per cent through premium services and 82 per cent occupancy.
Malaysia’s healthcare market offers compelling tailwinds. Private hospital demand grows 12 per cent annually. Medical tourism hit 1.4 million visitors pre‑pandemic, targeting 2 million by 2030. Government promotes “Health City” status with visa extensions.
Strategic location advantages shine. Sunway’s KL network captures affluent urbanites and expatriates. Penang facility targets northern industrial corridor. Velocity serves underserved Cheras township of 1 million residents.
Investor appetite reflects sector momentum. Comparable KPJ Healthcare trades at 32 times forward earnings. IHH Healthcare’s Pantai integration lifted margins 300 basis points. TPG’s Asia OneHealthcare IPO rumours add froth.
Proceeds allocation prioritises capacity. Velocity’s 500 beds add RM800 million annual revenue at 85 per cent occupancy. StarOne targets Penang’s medical tourism cluster. Digital health platform launches 2027.
Risks include medical inflation (8 per cent annually), doctor poaching and regulatory pricing caps. Sunway counters with vertical integration: in‑house labs, imaging and pharma cut costs 15 per cent.
Bursa Malaysia welcomes healthcare heavyweight. Listing elevates sector weighting to 5 per cent from 2 per cent. Government eyes insurance liberalisation to boost penetration from 45 per cent.
Sunway joins regional consolidation wave. Ramsay Sime Darby’s TPG exit, IHH Pantai merger set precedents. Full FDI opens doors to global capital. Malaysia emerges Southeast Asia’s healthcare IPO hub. The IPO cements Sunway’s leadership. RM2.86 billion fuels 2,000 bed pipeline. Medical tourism strategy targets US$1 billion annual revenue. Listing provides currency for M&A in Thailand, Indonesia.
